Latest Antimalarial drug Stories
First new lupus drug approved in 56 years SILVER SPRING, Md., March 9, 2011 /PRNewswire-USNewswire/ -- The U.S.
A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la SantÃ© et de la Recherche MÃ©dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria.
KOLDING, Denmark, Feb. 24, 2011 /PRNewswire/ -- Bestnet Europe Ltd. has been awarded a Certificate of Appreciation from Mama Dorcas Against Malaria (MADAM) for a donation of NetprotectÂ® Long Lasting Insecticide Incorporated Mosquito Nets (LLINs).
There are over 200 million cases of malaria each year and, according to the World Health Organisation, in 2009 malaria was responsible for 781,000 deaths worldwide.
Two separate studies â€“ carried out in Burkina Faso and Maliâ€“ have found that combining intermittent preventive treatment of malaria in children (IPTc) with insecticide-treated bednets (ITNs) can substantially reduce the incidence of severe malaria.
Three randomized controlled trials published in this week's PLoS Medicine show that intermittent preventive treatment of malaria in children adds to the benefit of sleeping under bednets and that this public health intervention is best delivered by community-based, volunteer village health workers.
A drug-resistant strain of malaria could spread from southeast Asia to Africa in as little as three months, which puts millions of children at risk, according to a warning from a leading expert Wednesday.
PERTH, Australia, Dec. 1, 2010 /PRNewswire/ -- This medical condition is currently endemic in 21 countries across Latin America killing more people in the region each year than any other parasite-born disease including malaria.
Giving emergency artesunate suppositories to children with suspected severe malaria before referring them for treatment is a cost-effective intervention that can substantially improve the management of childhood malaria in remote African settings.
ATLANTA, Nov. 9, 2010 /PRNewswire/ -- UCB (EURONEXT: UCB) and U.S. based partner Immunomedics Inc.